Hasenburg, Annette http://orcid.org/0000-0002-1547-4968
Plett, Hellmut
Krämer, Bernhard
Braicu, Elena
Czogalla, Bastian
Bossart, Michaela
Singer, Susanne
Mayr, Doris
Staebler, Annette
du Bois, Andreas
Kommoss, Stefan
Link, Theresa
Burges, Alexander
Heitz, Florian
Keul, Jacqueline
Trillsch, Fabian
Harter, Philipp
Wimberger, Pauline
Buderath, Paul
Klar, Maximilian
Funding for this research was provided by:
Celgene
Johannes Gutenberg-Universität Mainz
Article History
Received: 12 December 2020
Accepted: 23 February 2021
First Online: 21 July 2021
Declarations
:
: A. Hasenburg: Speaker honorarium: AstraZeneca; Celgen; MedConcept GmbH, Med update GmbH; Medicultus; Pfizer; Promedicis GmbH; Softconsult; Roche Pharma AG; Streamedup!GmbH; Tesaro Bio Germany GmbH, LEO Pharma, Advisory board: PharmaMar; Promedicis GmbH; Roche Pharma AG; Tesaro Bio Germany GmbH, AstraZeneca, LEO Pharma, MSD Sharp and Dohme GmbH. H. Plett: no COI. S. Kommoss: Honoraria for Advisory Boards and/or educational activities: Roche, Astra Zeneca, GSK/Tesaro, Myriad, Clovis. E. Braicu: Honoraria for Advisory Boards and/or educational activities: Roche Pharma, Astra Zeneca, Tesaro, Clovis, GSK, Abbvie, Genmab/Seattle Genetics, MSD, Incyte. Institutional Grants for studies: Bayer, Roche Diagnostics, MSD, Incyte. B. Czogalla: no COI. M. Bossart: no COI. S. Singer: lecture fees from BMS, Boehringer-Ingelheim, Lilly and Pfizer. D. Mayr: Novartis, Pfizer, GlaxoSmithKline. A. Staebler: no COI. A. Du Bois: Honoraria/Institutional Grants for Advisory Boards and/or educational activities: Roche, Astra Zeneca, GSK/Tesaro, Clovis, Pfizer, Biocad, Genmab/Seattle Genetics, MSD. B. Krämer: Roche and Astra Zeneca. T. Link: Personal fees: MSD, Amgen, Pfizer, Novartis, Teva, Tesaro, Roche, Clovis, Lilly. Non-financial support: Pfizer, Roche, Celgene. A. Burges: grants and personal fees from AstraZeneca, Roche and Tesaro. F. Heitz: personal fees and non-financial support from Roche, AstraZeneca, GSK and PharmaMar. J. Keul: no COI. F. Trillsch: grants and personal fees from AstraZeneca, Clovis, Medac, PharmaMar, Roche and Tesaro. P. Harter: Grants and personal fees from Astra Zeneca, Roche, Tesaro, Public funding (EU, ASCO, DKH, DFG) and GSK. Personal fees from Sotio, Stryker, Zai Lab, MSD, Clovis, Immunogen. Grants from Boehringer Ingelheim, Medac and Genmab. P. Wimberger: Honoraria/expences and consulting fees: Amgen, AstraZeneca, MSD Sharp and Dohme (Merck US), Novartis, Pfizer, PharmaMar, Roche, TEVA, Eisai, Clovis, Tesaro. Funded Research: Amgen, AstraZeneca, MSD Sharp and Dohme (Merck US), Novartis, Pfizer, PharmaMar, Roche, Clovis, Tesaro. P. Buderath: Congress Support, Travel expenses, speaker Honoraria: PharmaMar; AstraZeneca, MSD; Roche. M. Klar: Advisory board Tesaro/GSK.
: 513/13 Freiburg.